The primary hypothesis was that, although total levels of circulating CTRP3 will be similar between people with type 2 diabetes compared with nondiabetic controls, there will be a difference between groups in the circulating oligomeric state of CTRP3. This evidence concerns the gene C1QTNF3 and type 2 diabetes mellitus.